A barostim system was implanted on (b)(6) 2023.The patient wasn't doing well on (b)(6) 2023, and was admitted to the hospital on (b)(6) 2023 with hyponatremia presenting as loss of balance and dizziness.It was noted that the patient had decreased the dose of spironolactone after the implant procedure, and the spironolactone was discontinued on (b)(6) 2023.The patient was discharged home on (b)(6) 2023.In the opinion of the physician the root cause was unable to be determined but stated the barostim system could have contributed to the event.The patient reported they felt better with the barostim system, and no change was made to the therapy.
|
The results of the investigation are inconclusive at this time, and the reported device was not returned for analysis.Based on the information received, the cause of the reported event could not be conclusively determined.The device also remained implanted and the event was resolved with no changes to therapy.The device history and sterilization record for this device serial number has been reviewed.No issues or discrepancies were noted during this review that would have contributed to the reported event.The device met material, assembly, and quality control requirements.Cvrx id# (b)(4).
|